Ransomware Attacks in Manufacturing Doubled From 2019
From 2019 to 2021, ransomware attacks in manufacturing doubled, making it the most commonly targeted industry in 2020 and 2021, according to Advisen loss data. Advisen’s loss database contains 3,415 ransomware attacks and 189 ransomware attacks in manufacturing.
The manufacturing industry is a high-value target for ransomware attacks. Most manufacturers have embraced automation and digitization, but many only store files locally, leaving them vulnerable to attack.
Manufacturing companies also store high-value data, such as intellectual property and trade secrets, which makes manufacturers more likely to pay if their information is stolen or hackers threaten to publish it online. In some cases, hackers will steal data involving third parties as well, such as clients, suppliers and partners. This gives them even more leverage to extort money in a ransomware attack.
In addition to ransom payments, ransomware attacks on manufacturing can also be extremely costly in terms of response and business interruption costs. For example, the ransomware attack on meat supplier JBS Foods on May 31, 2021, resulted in a total shutdown of operations and an $11 million ransom, according to Advisen loss data.
Looking at ransomware losses by industry over time, public administration and health care were some of the most frequently targeted industries from 2013 to 2019; manufacturing accounted for a relatively small percentage of total ransomware attacks. However, by 2020, manufacturing became the most commonly targeted industry.
Within the manufacturing industry, computer and electronic product manufacturing saw nearly double the number of ransomware attacks than any other category at 32%. These attacks include ransomware attacks on an Apple supplier, Samsung Electronics and Bose Corporation, according to Advisen loss data.
Chemical manufacturing accounted for 14% of the remaining losses, while machinery manufacturing and transportation equipment manufacturing each accounted for 12%, according to Advisen loss data.
Contact INSURICA today to learn more about our manufacturing industry services and capabilities.
© 2022 Zywave, Inc. All rights reserved.
About the Author
Share This Story
Related Blogs
Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now
When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.
The New Era of Mental Health Parity Enforcement in 2026
Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.
The 2026 Specialty Drug Surge: What Employers Need to Prepare For
Specialty drugs have been a major cost driver for years, but 2026 marks a significant shift in both scale and urgency. With GLP 1 medications expanding into new indications, gene therapies entering the market at record pace, and oncology drugs continuing to rise in both cost and utilization, specialty medications are projected to account for more than 60% of total pharmacy spending this year. That’s a dramatic change for employers, especially considering that specialty drugs represent fewer than 5% of total prescriptions.